Trending...
- Saluting a record year for CHP cadets, California's next generation of law enforcement officers
- California: Newsom blasts CDC panel after vote to end universal newborn hepatitis B vaccinations
- DanReDev, Kaufman Development & Oldivai Announce Major 2026 Projects Nationwide
CASTRO VALLEY, Calif. - Californer -- Veyond Metaverse, the most advanced extended reality (XR) technology platform, is pleased to announce the addition of three new members to its Advisory Board. The new members are Dr. James Snider, John Erickson, and Jim McMenamy. James Snider, a current CEO at Critical Diagnostics, brings unparalleled experience and clinical expertise in the cardiovascular business career spanning three decades. James is a great complement to Veyond Metaverse and adds a unique perspective, given his accomplished cardiovascular IVD and business career.
John Erickson is a dynamic and strategic senior global health care business leader with success-based experience from Fortune 50 to start-ups including Johnson & Johnson, Abbott, Bio-Rad, Nexus Dx, and as a consultant to diabetes, clinical diagnostic, and life science companies. John has been recognized for proven leadership in delivering superior results, developing profitable growth strategies, and building high-performance teams. Additionally, John has been responsible for developing, launching, and managing over three dozen scientific products with cumulative revenues in excess of $4 billion and has raised more than $50 million in investment capital. John's experiential portfolio and business acumen also include strategy development and execution, capital funding, organizational design, and cultural change management, numerous global new product launches, joint venture management, corporate partnerships, product licensing agreements, intellectual property strategy, Digital Health, and Point of Care (POC), and emerging market development expertise. John's experience will be a critical value for Veyond Metaverse.
More on The Californer
Jim McMenamy has spent the last 30+ years focusing primarily on the development and worldwide launch of numerous Human and Veterinary Clinical Diagnostic Test Systems with a specific focus on the Point of Care Marketplace. He has launched dozens of new products in Infectious Diseases, Cancer Markers, Fertility Tests, Drugs of Abuse, etc., both Instrumented and non-Instrumented. He has held leadership positions in Marketing, Sales, Business Development, Corporate Development, and General Management with companies such as Samsung (NexusDx), Becton Dickinson, Quidel, ACON Labs, Alere/Inverness Medical, scil/Henry Schein Animal Health, and diatron/Stratec Corp.
"We are very excited to have James, John, and Jim join our Advisory Board here at Veyond Metaverse! The new advisory board is a great complement to our experienced executive team and adds a unique perspective, given their long and successful business career. All three advisors are a well-known leader in the key areas where Veyond Metaverse is focused, making their appointment a strategic and integral part of our company growth."
— Adam Choe, Co-founder, and CEO, Veyond Metaverse
More on The Californer
About Veyond Metaverse
Veyond Metaverse offers a new and disruptive XR technology to medical education, surgical planning, and training, augmented assisted surgical operations, pharmaceutical, oncology treatment, and diagnosis. Our proprietary communication platform enables global engagement and collaboration seamlessly, creating a more accessible, user-friendly ecosystem by leveraging the most advanced communication capabilities. We seek to improve medical education, surgical training, save patients' lives by enhancing surgery, diagnosis, and expand worldwide access through the proprietary cloud platform. Veyond Metaverse is based in Silicon Valley, CA. Visit www.veyondmetaverse.com
John Erickson is a dynamic and strategic senior global health care business leader with success-based experience from Fortune 50 to start-ups including Johnson & Johnson, Abbott, Bio-Rad, Nexus Dx, and as a consultant to diabetes, clinical diagnostic, and life science companies. John has been recognized for proven leadership in delivering superior results, developing profitable growth strategies, and building high-performance teams. Additionally, John has been responsible for developing, launching, and managing over three dozen scientific products with cumulative revenues in excess of $4 billion and has raised more than $50 million in investment capital. John's experiential portfolio and business acumen also include strategy development and execution, capital funding, organizational design, and cultural change management, numerous global new product launches, joint venture management, corporate partnerships, product licensing agreements, intellectual property strategy, Digital Health, and Point of Care (POC), and emerging market development expertise. John's experience will be a critical value for Veyond Metaverse.
More on The Californer
- Relief Alliance Skid Row Outreach Brings Celebrities and Volunteers Together for Community Impact
- Terizza Forms Strategic Collaboration with UC San Diego to Pioneer Next-Generation Distributed AI Infrastructure
- Car Wash in Northridge Under $10
- Only 3 Spots Left for Rise Within: Wellness Retreat Los Cabos – January 2026
- EnergyStrat Launches Global LNG Risk Outlook 2025–2030
Jim McMenamy has spent the last 30+ years focusing primarily on the development and worldwide launch of numerous Human and Veterinary Clinical Diagnostic Test Systems with a specific focus on the Point of Care Marketplace. He has launched dozens of new products in Infectious Diseases, Cancer Markers, Fertility Tests, Drugs of Abuse, etc., both Instrumented and non-Instrumented. He has held leadership positions in Marketing, Sales, Business Development, Corporate Development, and General Management with companies such as Samsung (NexusDx), Becton Dickinson, Quidel, ACON Labs, Alere/Inverness Medical, scil/Henry Schein Animal Health, and diatron/Stratec Corp.
"We are very excited to have James, John, and Jim join our Advisory Board here at Veyond Metaverse! The new advisory board is a great complement to our experienced executive team and adds a unique perspective, given their long and successful business career. All three advisors are a well-known leader in the key areas where Veyond Metaverse is focused, making their appointment a strategic and integral part of our company growth."
— Adam Choe, Co-founder, and CEO, Veyond Metaverse
More on The Californer
- bisco industries New Authorized Line: SKF Aerospace
- Strong Revenue Gains, Accelerating Growth, Strategic Hospital Expansion & Uplisting Advancements: Cardiff Lexington Corporation (Stock Symbol: CDIX)
- Baby Boomers: The Perfect Cash Buyers in Today's Market
- Stray Theories Unveils Falter, an Atmospheric Passage Through the Spaces Between Doubt and Hope
- Holiday Decorations Most Likely to Cause Injuries
About Veyond Metaverse
Veyond Metaverse offers a new and disruptive XR technology to medical education, surgical planning, and training, augmented assisted surgical operations, pharmaceutical, oncology treatment, and diagnosis. Our proprietary communication platform enables global engagement and collaboration seamlessly, creating a more accessible, user-friendly ecosystem by leveraging the most advanced communication capabilities. We seek to improve medical education, surgical training, save patients' lives by enhancing surgery, diagnosis, and expand worldwide access through the proprietary cloud platform. Veyond Metaverse is based in Silicon Valley, CA. Visit www.veyondmetaverse.com
Source: Veyond Metaverse
Filed Under: Medical
0 Comments
Latest on The Californer
- Big Al's Grime Fighters Opens Limited Spots for New Commercial Clients After Years of High Demand
- Long Beach Health Department Awarded Three Grants to Expand Traffic Safety and Education Programs
- From Tragedy to Testimony: Alreddy Reddy Delivers Life Story Through Music
- Did Drake's "Ice Man" Secretly Launch a New 8,000+ Artist AI Music Marketplace?
- Hyatt House Fresno Celebrates Grand Opening, Introducing the First Hyatt House in Fresno, California
- "I Make Music Not Excuses" Journal by Anthony Clint Jr. Becomes International Amazon Best Seller, Empowering Music Creators Worldwide
- California: Cannabis crackdown: State officials seize 58,350 illegal cannabis plants worth $57 million in November
- Consortium Media Appoints Jennifer Curtis-Neves as President of Consortium Media
- DanReDev, Kaufman Development & Oldivai Announce Major 2026 Projects Nationwide
- SEEAG Awarded $236,360 California Department of Food and Agriculture Grant
- Emerging Actress Makes a Surprise Appearance in Stranger Things 5
- California: Earthquake system shows that failure is Trump's default setting
- Federal Court to Trump: keeping a standing army is illegal, the federalization of California's National Guard must end
- Accelerating Precious Metals Expansion and Digital Asset Innovation Ahead of 2026: Asia Broadband Inc. (Stock Symbol: AABB)
- P.O.W.E.R. Officially Launches New Association
- Call For Entries – New Media Film Festival Iconic. Real. Connected
- Pier 210 Dental Group and Dr. David Roholt Offers Non-Invasive TMJ pain and Sleep Disorder Therapies
- Affordable Car Wash in Northridge CA
- VizComm Signs & Graphics Introduces Custom Wall Murals as the New Must-Have for Corporate Interiors in 2026
- Best Car Wash in Northridge CA Cheapest Car Wash in Northridge